WHO ICTRP trial
Dose Ranging Trial to Evaluate the Safety, Tolerability, Extended Early…
PACTR201104000281203 · Pan African Clinical Trials Registry (PACTR) · Not Recruiting
Key facts
| Trial ID | PACTR201104000281203 |
|---|---|
| Public title | Dose Ranging Trial to Evaluate the Safety, Tolerability, Extended Early Bactericidal Activity and Pharmacokinetics of Higher Doses of Rifampicin |
| Scientific title | A Phase IIA Dose Ranging Trial to Evaluate the Safety, Tolerability, Extended Early Bactericidal Activity and Pharmacokinetics of Higher Doses of Rifampicin in Adult Subjects with Newly Diagnosed, Uncomplicated, Smear-Positive, Pulmonary Tuberculosis. |
| Primary sponsor | Radboud University Nijmegen Medical Centre |
| Secondary sponsors | Prof. David Burger, PharmD, PhD |
| Registry | Pan African Clinical Trials Registry (PACTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | South Africa;South Africa |
| Conditions | Tuberculosis;Tuberculosis |
| Interventions | 10 mg Rifampicin/kg;20 mg/kg Rifampicin/kg;25 mg/kg Rifampicin/kg;30 mg/kg Rifampicin/kg;35 mg/kg Rifampicin/kg;40mg/kg Rifampicin |
| Registration date | Mar 22, 2011 |
| Target size | 68 |
| Registry page | pactr.samrc.ac.za |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: